– April 18-22, 2026 | Chicago –
Zy Therapeutics will be attending the American Academy of Neurology (AAN) Annual Meeting 2026 in Chicago, where the team will continue engaging with the neurology community and highlighting the scientific and clinical development of KaminiTM as a potential disease-modifying therapy for rare neurological disorders, including Sturge–Weber Syndrome.
As always, we look forward to connecting with colleagues, collaborators, and potential partners who share our commitment to advancing innovation in rare neurological disease.
